Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy

Bibliographic Details
Title: Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy
Authors: Yuji Shimada, Mariko Hojo, Yuji Kita, Yuji Ikeda, Sho Sato, Ayato Murata, Shunsuke Sato, Kohei Matsumoto, Yoichi Akazawa, Tsutomu Takeda, Kumiko Ueda, Hiroya Ueyama, Tomoyoshi Shibuya, Takuya Genda, Akihito Nagahara
Source: Diagnostics, Vol 12, Iss 10, p 2364 (2022)
Publisher Information: MDPI AG, 2022.
Publication Year: 2022
Collection: LCC:Medicine (General)
Subject Terms: gastric mucosal injury, dual antiplatelet therapy, single antiplatelet therapy, low-dose aspirin, clopidogrel, Medicine (General), R5-920
More Details: Background: Patients taking low-dose aspirin have a higher incidence of gastroduodenal ulcers and higher risk of upper gastrointestinal bleeding than patients who do not. Thienopyridine antiplatelet agents may similarly cause bleeding gastroduodenal erosions and ulcers. The incidence of gastrointestinal bleeding is reported to be higher when these antithrombotic drugs are used in combination. Until now, most studies have focused on bleeding, and no study has compared the degree of gastric mucosal injury between patients receiving dual antiplatelet therapy (DAPT) and those receiving single antiplatelet therapy (SAPT) in real-world clinical practice. Aim: Our objective was to compare the degree of gastric mucosal injury in patients taking low-dose aspirin in combination with clopidogrel (one of the thienopyridine antiplatelet agents) with that of patients who were taking aspirin or clopidogrel as a single agent. Methods: Patients who were taking aspirin and/or clopidogrel and who underwent scheduled esophagogastroduodenoscopy between April 2015 and March 2020 were enrolled in this study. Endoscopic images were reviewed retrospectively, and the degree of gastric mucosal injury was assessed with the modified Lanza score (m-Lanza score). The m-Lanza score was compared between DAPT patients taking aspirin and clopidogrel and SAPT patients taking either aspirin alone or clopidogrel alone. Results: The m-Lanza scores of the DAPT group, the aspirin group, and the clopidogrel group were 1.67 ± 1.81 (mean ± standard deviation), 0.95 ± 1.61, and 0.72 ± 1.29, respectively. The m-Lanza score of the DAPT group tended to be higher than that of the aspirin group (p = 0.06) and was significantly higher than that of the clopidogrel group (p = 0.03). Conclusion: The degree of gastric mucosal injury in DAPT patients was significantly higher than that in patients using clopidogrel alone and tended to be higher than that in patients using aspirin alone in real-world clinical practice.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2075-4418
Relation: https://www.mdpi.com/2075-4418/12/10/2364; https://doaj.org/toc/2075-4418
DOI: 10.3390/diagnostics12102364
Access URL: https://doaj.org/article/afd3f6a769224c449a672408f3e85a20
Accession Number: edsdoj.fd3f6a769224c449a672408f3e85a20
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:20754418
DOI:10.3390/diagnostics12102364
Published in:Diagnostics
Language:English